Home > Financing and Incentives > Emerging Technology & Life Sciences > Biotech Incubator & Research Park > CCIT Tenants
  • Print
  • Send to email


CCIT Tenants

API Pharma Tech LLC


API Pharma Tech LLC  is a research based technology development and drug substance, drug products manufacturing & marketing company operated by highly skilled and expert scientists and business strategists.

Angex Pharmaceuticals Inc.

Angex Pharmaceuticals is engaged in the discovery and development of innovative medicines to address the unmet medical needs for the improvement of human health.

Aucta Pharmaceuticals, LLC


Aucta Pharmaceuticals, LLC. (AUCTA, latin-improved, enhanced) is founded by experienced pharmaceutical research scientists from the U.S. and China, and managed by U.S. pharma industry veterans. The company is located in both China and New Jersey. Their expertise is new drug product development, product label improvement and solving difficult technical issues. They have solid fundamentals and sophisticated technology platform that can rapidly tackle technical issues and propose new product concept. The company will be in the business of novel and generic formulation product development. They work with pharma companies around the world for product co-development, sponsored research and provide value adding solutions to their partners and projects.

Bellerophon Therapeutics

Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. The mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. They are currently developing three product candidates, two based on their proprietary pulsatile nitric oxide delivery device, which is referred to as INOpulse, and a third device which is referred to as bioabsorbable cardiac matrix, or BCM.

BioAegis Therapeutics Inc.

BioAegis Therapeutics Inc. is a clinical stage entity commercializing groundbreaking discoveries in inflammation and infection, directed at addressing serious diseases. The Company is pursuing a portfolio of high value indications based on repletion of plasma gelsolin, an integral and ubiquitous, natural human protein.

Celmatix Clinical Laboratories LLC (CCL)
Celmatix Clinical Laboratories LLC (CCL) manages the laboratory and testing functions of Celmatix's next generation fertility test.  Celmatix is a personalized medicine company focused on fertility and women’s health. The company leverages big data and genomics to create products that bring greater clarity to the treatment of infertility and pave the way for proactive fertility management.  Founded in 2009 and headquartered in New York City, Celmatix is committed to empowering women with data driven insights about their reproductive health

Genomic Prediction Inc.

Genomic Prediction offers state-of-the-art preimplantation genetic testing services including amplification products, and testing for aneuploidy, single gene disorders and polygenic disorders.

Grace Therapeutics LLC


Grace Therapeutics LLC is a start-up life science company. Their goal is to develop improved formulations of select approved drugs including combination drugs for existing and/or additional therapeutic indications. They also intend to develop innovative drug delivery systems that improve the clinical outcome of currently marketed products. Their management team and network of consultant experts are experienced at founding and growing companies from the earliest stages of development through product approval and commercialization.

Health Interactive Inc.

Health Interactive (HI) is a digital health company providing bioinformatics data analysis.  HI provides bioinformatics analytical services for genetic testing, pharmacogenomic analysis, inherited disorders including cancers, cancer gene mutations, and other genomic analyses.

Hudson BioPharma, Inc.


Hudson BioPharma Inc. has incorporated in New Jersey and was created to develop anti-cancer medicines through utilization of their proprietary technology in the design and synthesis of drug leads targeting protein-to-protein interaction. The primary focus of Hudson BioPharma will be on utilizing tumor protein P53 (a natural tumor suppressor that regulates cell division by keeping cells from growing and dividing too fast or in an uncontrolled way), to develop an anti-cancer medicine.

Innovera Pharmaceuticals
Innovera Pharmaceuticals specializes in the development of unique generic and branded products possessing development barriers. Innovera’s experience in developing  challenging products including patent challenges and setting up vertically integrated pharmaceutical companies that manufacture active raw materials, finished dosage forms and sell the finished products.  Innovera Pharmaceuticals is also developing improved formulations of select approved drugs including combination drugs for therapeutic indications. 


Kamat Pharmatech, LLC


Kamat Pharmatech, LLC is a newly formed company that will operate as a contract research organization while developing its own technology focussing in the area of injectable products such as anti-inflammatory drugs that target autoimmune diseases.



Novanex is a US-based medical device company that develops and commercializes innovative device and technology to monitor or detect disease conditions or status. Their first developmental product, OMC100, monitors and displays the blood glucose level non-invasively in two minutes. The system is designed for use in hospitals as well as in outpatient sites and homes.


PDS Biotechnology Corporation

PDS Biotechnology is harnessing the newly discovered properties of specific synthetic positively charged (cationic) lipids to develop a new generation of more versatile, simpler, safer and significantly more potent B- and T-cell activating vaccines. PDS’s proprietary Versamune™ platform nanotechnology when combined with T-cell antigens leads to superior cures for infection and cancer.


Quixgen Inc. is a startup pharmaceutical company dedicated to drug discovery in the areas of infectious diseases, dysmetabolic and inflammatory diseases.

SkinAxis, LLC


SkinAxis, LLC is a biotechnology company providing unique research and development services for the pharmaceutical, biotechnology, chemical, and cosmetic industries involved with drug and active ingredient discovery.  Their exclusive in-house technology provides important, reliable, and previously unobtainable data on human skin and lip responses for drug and active ingredient discovery.

SPES Pharmaceuticals
SPES Pharmaceuticals is an innovative pharmaceutical technology company dedicated to provide medications with improved clinical benefits and patient compliance through development of innovative formulation and drug delivery technologies. 

Urigen Pharmaceuticals Inc. 


Urigen Pharmaceuticals specializes in the design and implementation of innovative products for patients with urological ailments including, specifically, the development of innovative products for amelioration of Painful Bladder Syndrome (PBS), Urethritis, Nocturia and Over Active Bladder (OAB).

Visikol Inc.


Visikol Inc is a biotechnology company which is focused on disrupting the bio-imaging field through leveraging its patent-pending chemical clearing agent Visikol®. The Visikol technology is an enabling technology which the company is utilizing to develop novel imaging platforms for developmental toxicology studies and 3-dimensional histology.